Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2021 2020
Total Assets 51.7 Million 19.4 Million
Total Current Assets 51.64 Million 19.33 Million
Cash And Short Term Investments 26.41 Million 7.23 Million
Cash and Cash Equivalents 26.41 Million 7.23 Million
Short Term Investments - -
Net Receivables 6.34 Million 4.4 Million
Inventory 14.21 Million 5.85 Million
Other Current Assets 4.67 Million 1.84 Million
Total Non-Current Assets 65 Thousand 64 Thousand
Net PPE 65 Thousand 64 Thousand
Good Will And Intangible Assets - -
Good Will - -
Intangible Assets - -
Long-Term Investments - -
Tax Assets - -
Other Non Current Assets - -
Other Assets - -
Total Liabilities 67.62 Million 345.18 Million
Total Current Liabilities 66.06 Million 59.81 Million
Account Payables 13.94 Million 12.1 Million
Tax Payables - -
Short Term Debt 42.26 Million 41.9 Million
Deferred Revenue 1.58 Million 1.17 Million
Other Current Liabilities 8.26 Million 4.63 Million
Total Non Current Liabilities 1.56 Million 285.36 Million
Long-Term Debt - 87.17 Million
Deferred Revenue Non Current - -
Deferred Tax Liabilities Non Current - -
Other Non Current Liabilities - 198.19 Million
Other Liabilities - -
Total Equity -15.91 Million -325.78 Million
Stock Holders Equity -15.91 Million -325.78 Million
Common Stock 2000.00 -
Retained Earnings -321.65 Million -325.78 Million
Accumulated other comprehensive income - -
Common Stock Equity -15.91 Million -325.78 Million
Capital Lease Obligation - -
Total Investments - -
Total Debt 42.26 Million 129.07 Million
Net Debt 15.85 Million 121.84 Million

Balance Sheet Charts